Evolving Mass Tort Litigation: GLP-1 RA Weight Loss Drugs and the Emerging Gastroparesis Crisis
Introduction In recent years, the use of GLP-1 receptor agonists (GLP-1 RAs) for weight loss has grown exponentially. These drugs, originally approved by the FDA for diabetes management, have been embraced by patients and physicians alike for their promising effects on shedding excess pounds. However, as their popularity surged, so did concerns over their safety […]